--- title: "Cutia Therapeutics (2487) stock: news and investor profile" url: "https://aibio.space/companies/cutia-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Cutia Therapeutics (HKEX: 2487), China. The directory classifies it as Pharmaceuticals: Major." --- 2487 Cutia Therapeutics HKEX · China # Cutia Therapeutics (2487) news Cutia Therapeutics is a public biotech or pharmaceutical company listed on HKEX under the ticker 2487, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Cutia Therapeutics news We have not published a story on Cutia Therapeutics yet. When there is news, it will appear here. ## Cutia Therapeutics at a glance - **Ticker**: 2487 - **Listing**: HKEX - **Country**: China ### Related companies - [Beijing Centergate Technologies (Holding) Co.](https://aibio.space/companies/beijing-centergate-technologies/) SZSE: 000931 - [Guizhou Bailing Group Pharmaceutical Co.](https://aibio.space/companies/guizhou-bailing-pharmaceutical/) SZSE: 002424 - [Shanghai Henlius Biotech](https://aibio.space/companies/shanghai-henlius-biotech/) HKEX: 2696 - [Youcare Pharmaceutical Group Co.](https://aibio.space/companies/youcare-pharmaceutical/) SSE: 688658 - [Zhejiang Jingxin Pharmaceutical Co.](https://aibio.space/companies/zhejiang-jingxin-pharmaceutical/) SZSE: 002020 - [PKU Healthcare Corp.](https://aibio.space/companies/pku-healthcare/) SZSE: 000788 - [HUBEI JUMPCAN PHARMACEUTICAL CO., LTD](https://aibio.space/companies/hubei-jumpcan-pharmaceutical/) SSE: 600566 - [Anhui Anke Biotechnology (Group) Co.](https://aibio.space/companies/anhui-anke-biotechnology/) SZSE: 300009 ### Also on HKEX - [B&K Corporation](https://aibio.space/companies/b-k/) 2396 - [Viva Biotech Holdings](https://aibio.space/companies/viva-biotech/) 1873 - [Alebund Pharmaceuticals (Jiangsu)](https://aibio.space/companies/alebund-pharmaceuticals-jiangsu/) 9637 - [Jacobson Pharma Corporation](https://aibio.space/companies/jacobson-pharma/) 2633 - [LongBio Pharma (Suzhou) Co.](https://aibio.space/companies/longbio-pharma-suzhou/) 1779 - [HJ Science Co.](https://aibio.space/companies/hj-science/) 6132 ## Questions about Cutia Therapeutics What is the ticker symbol of Cutia Therapeutics? Cutia Therapeutics trades under the ticker 2487 on HKEX. Where is Cutia Therapeutics listed? Cutia Therapeutics is listed on HKEX. Which country or territory is Cutia Therapeutics listed under? Our directory records Cutia Therapeutics under China. What does Cutia Therapeutics do? Our directory classifies Cutia Therapeutics as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Cutia Therapeutics? The ISIN recorded for Cutia Therapeutics is KYG2606C1006. Does aibio.space cover Cutia Therapeutics? aibio.space lists Cutia Therapeutics among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Cutia Therapeutics? Companies in our directory listed in the same country and business area as Cutia Therapeutics: Beijing Centergate Technologies (Holding) Co., Guizhou Bailing Group Pharmaceutical Co., Shanghai Henlius Biotech, Youcare Pharmaceutical Group Co., Zhejiang Jingxin Pharmaceutical Co., PKU Healthcare Corp.. ## Investor discussion: Cutia Therapeutics Members talk about Cutia Therapeutics (2487). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Cutia Therapeutics, newest first. Each line links the filing it comes from. 1. 2025-09-05 Financings Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0905/2025090500327.pdf) 2. 2025-08-28 Financings Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082900185.pdf) ## Press releases Headlines of Cutia Therapeutics's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-20 HKEXnews [VOLUNTARY ANNOUNCEMENT - LATEST UPDATE ON THE COOPERATION WITH REJUVEN](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1021/2026102100001.pdf) 2. 2026-09-30 HKEXnews [VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PROGRAM UNDER THE SHARE REPURCHASE MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093000714.pdf) 3. 2026-09-30 HKEXnews [CHANGE OF EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093000438.pdf) 4. 2026-09-20 HKEXnews [VOLUNTARY ANNOUNCEMENT - CU-40102 (TOPICAL FINASTERIDE SPRAY) OBTAINED MARKETING APPROVAL BY THE MACAO PHARMACEUTICAL ADMINISTRATION BUREAU](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0921/2026092100093.pdf) 5. 2026-09-02 HKEXnews [VOLUNTARY ANNOUNCEMENT - BIOLOGICS LICENSE APPLICATION FOR CU-20101 (BOTULINUM TOXIN TYPE A FOR INJECTION) ACCEPTED BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0903/2026090300005.pdf) 6. 2026-08-31 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083100536.pdf) 7. 2026-06-26 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600411.pdf) 8. 2026-05-06 HKEXnews [VOLUNTARY ANNOUNCEMENT - CU-30101 (LOCALIZED TOPICAL LIDOCAINE AND TETRACAINE CREAM) OBTAINED DRUG MARKETING AUTHORIZATION BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0507/2026050700027.pdf) 9. 2026-04-27 HKEXnews [CHANGE OF NAME OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE AND REGISTERED OFFICE IN THE CAYMAN ISLANDS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042702954.pdf) 10. 2026-04-24 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400834.pdf) 11. 2026-04-13 HKEXnews [VOLUNTARY ANNOUNCEMENT - COMPLETION OF PHASE III CLINICAL TRIAL OF CU-20101 (BOTULINUM TOXIN TYPE A FOR INJECTION) FOR IMPROVING MODERATE TO SEVERE GLABELLAR LINES IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041300057.pdf) 12. 2026-03-24 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0324/2026032400296.pdf) 13. 2026-03-16 HKEXnews [VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPLICATION OF CU-40104 (TOPICAL DUTASTERIDE AGENT) OBTAINED CLINICAL TRIAL APPROVAL BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0316/2026031600123.pdf) 14. 2026-01-19 HKEXnews [VOLUNTARY ANNOUNCEMENT - CU-20101 (BOTULINUM TOXIN TYPE A FOR INJECTION) FOR IMPROVING MODERATE TO SEVERE GLABELLAR LINES ACHIEVED POSITIVE TOPLINE RESULTS FROM PHASE III CLINICAL TRIAL IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0119/2026011900099.pdf) 15. 2025-12-30 HKEXnews [CHANGE OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1230/2025123000330.pdf) 16. 2025-11-18 HKEXnews [VOLUNTARY ANNOUNCEMENT - ABBREVIATED NEW DRUG APPLICATION FOR CU-40105 (SELF-DEVELOPED TOPICAL FINASTERIDE SPRAY) ACCEPTED BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1119/2025111900001.pdf) 17. 2025-11-10 HKEXnews [VOLUNTARY ANNOUNCEMENT - POST-HOC ANALYSIS OF PHASE III CLINICAL TRIAL OF CU-10201 (TOPICAL 4% MINOCYCLINE FOAM) IN THE PRC ACCEPTED FOR ORAL PRESENTATION AT THE 20TH CDA ANNUAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1110/2025111000013.pdf) 18. 2025-09-05 HKEXnews [COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0905/2025090500327.pdf) 19. 2025-08-28 HKEXnews [PLACING OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082900185.pdf) 20. 2025-08-28 HKEXnews [(1) CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE, PROCESS AGENT; AND (2) CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0828/2025082800642.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2487 on TradingView](https://www.tradingview.com/symbols/HKEX-2487/). ## Listing details Cutia Therapeutics is a public biotech or pharmaceutical company listed on HKEX under the ticker 2487, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Cutia Therapeutics - **Ticker**: 2487 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG2606C1006 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2487/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/cutia-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Cutia Therapeutics (2487) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/cutia-therapeutics/